Abstract
We have examined the developmental expression of the murine breast and ovarian cancer susceptibility gene, Brca1, to investigate its role in the control of cell growth and differentiation. Specifically, we have analysed Brca1 expression during embryonic development, in adult tissues, and during postnatal mammary gland development, particularly in response to ovarian hormones. Our results suggest that Brca1 is expressed in rapidly proliferating cell types undergoing differentiation. In the mammary gland, Brca1 expression is induced during puberty, pregnancy, and following treatment of ovariectomized animals with 17β–estradiol and progesterone. These observations imply that Brca1 is involved in the processes of proliferation and differentiation in multiple tissues, notably in the mammary gland in response to ovarian hormones.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Miki, Y. et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266, 66–71 (1994).
Easton, D.F., Bishop, D.T., Ford, D. & Crockford, G.P., Linkage consortium. Genetic linkage analysis in familial breast and ovarian cancer. Results from 214 families. Am. J. hum. Genet. 52, 678–701 (1993).
Smith, S.A., Easton, D.G., Evans, D.G.R. & Ponder, B.A.J. Allele losses in the region 17q12–21 in familial breast and ovarian cancer involve the wild-type chromosome. Nature Genet. 2, 128–131 (1992).
Thompson, M.E., Jensen, R.A., Obermiller, P.S., Page, D.L. & Holt, J.T. Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression. Nature Genet. 9, 444–450 (1995).
Merajver, S.D. et al. Somatic mutations in the Brca1 gene in sporadic ovarian tumours. Nature Genet. 9, 439–443 (1995).
Hosking, L. et al. A somatic Brca1 mutation in an ovarian tumor. Nature Genet. 9, 343–344 (1995).
Futreal, P.A. et al. Brca1 mutations in primary breast and ovarian carcinomas. Science 266, 120–122 (1994).
Ford, D. et al. Risks of cancer in Brca1 -mutation carriers. Lancet 343, 692–695 (1994).
Russo, J. & Russo, I.H. Development pattern of human breast and susceptibility to carcinogenesis. Eur. J. Cancer Prev. 2 (Suppl. 3), 85–100 (1993).
Schmid, P., Lorenz, A., Hameister, H. & Montenarh, M. Expression of p53 during mouse embryogenesis. Development 113, 857–865 (1991).
Gavin, B.J. & McMahon, A.P. Differential regulation of the Wnt gene family during pregnancy and lactation suggests a role in postnatal development of the mammary gland. Molec. Cell. Biol. 12, 2418–2423 (1992).
Buhler, T.A., Dale, T.C., Kieback, C., Humphreys, R.C. & Rosen, J.M. Localization and quantification of Wnt-2 gene expression in mouse mammary development. Dev. Biol. 155, 87–96 (1993).
Morrison, B.W. & Leder, P. neu and ras initiate murine mammary tumors that share genetic markers generally absent in c-myc and int-2-initiated tumors. Oncogene 9, 3417–3426 (1994).
Hobbs, A.A., Richards, D.A., Kessler, D.J. & Rosen, J.M. Complex hormonal regulation of rat casein gene expression. J. Biol. Chem. 257, 3598–3605 (1982).
McMaster, M.T., Teng, C.T., Dey, S.K. & Andrews, G.K. Lactoferrin in the mouse uterus: Analyses of the preimplantation period and regulation by ovarian steroids. Molec. Endocrinol. 6, 101–111 (1992).
Walmer, D.K., Wrona, M.A., Hughes, C.L. & Nelson, K.G. Lactoferrinexpression in the mouse reproductive tract during the natural estrous cycle: correlation with circulating estradiol and progesterone. Endocrinology 131, 1458–1466 (1992).
Almon, E. et al. Tissue-specific expression of the p53 suppressor gene. Devel. Biol. 156, 107–116 (1993).
Merritt, A.J. et al. The role of p53 in spontaneous and radiation-induced apoptosis in the gastrointestinal tract of normal and p53-deficient mice. Cancer Res. 54, 614–617 (1994).
Rogel, A., Popliker, M., Webb, C.G. & Oren, M. p53 cellular tumor antigen: Analysis of mRNA levels in normal adult tissues, embryos, and tumors. Molec. cell. Biol. 5, 2851–2855 (1985).
Reich, N.C. & Levine, A.J. Growth regulation of a cellular tumour antigen, p53, in nontransformed cells. Nature 308, 199–201 (1984).
Lane, D.P. DPp53 and human cancers. Br. med. Bull. 50, 582–599 (1994).
Mercer, W.E., Avignolo, C. & Baserga, R. Role of the p53 protein in cell proliferation as studied by microinjection of monoclonal antibodies. Molec. cell. Biol. 4, 276–281 (1984).
Russo, J., Tay, L.K. & Russo, I.H. Differentiation of the mammary gland and susceptibility to carcinogenesis. Breast Cancer Res. Treat. 2, 5–73 (1982).
McGregor, H. et al. Breast cancer incidence among atomic bomb survivors, Hiroshima and Nagasaki, 1950-69. J. nat Cancer Inst. 59, 799–811 (1977).
Boice, J.D., & Monson, R.R. Breast cancer in women after repeated fluoroscopic examinations of the chest. J. nat. Cancer Inst. 59, 823–832 (1977).
MacMahon, B. et al. Age at first birth and breast cancer risk. Bull. World Hlth. Org. 43, 209–21 (1970).
Chirgwin, J.M., Przybyla, A.E., MacDonald, R.J. & Rutter, W.J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18, 5294–5299 (1979).
Engelhardt, J.F. et al. Submucosal glands are the predominant site of CFTR expression in the human bronchus. Nature Genet. 2, 240–248 (1992).
Wilkinson, D.G. In situ hybridization: a practical approach (IRL Press, Oxford, 1992).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Marquis, S., Rajan, J., Wynshaw-Boris, A. et al. The developmental pattern of Brca1 expression implies a role in differentiation of the breast and other tissues. Nat Genet 11, 17–26 (1995). https://doi.org/10.1038/ng0995-17
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ng0995-17
This article is cited by
-
BRCA1 expression, proliferative and apoptotic activities in ovarian epithelial inclusions
Journal of Ovarian Research (2017)
-
Germline mutations of BRCA1 gene exon 11 are not associated with platinum response neither with survival advantage in patients with primary ovarian cancer: understanding the clinical importance of one of the biggest human exons. A study of the Tumor Bank Ovarian Cancer (TOC) Consortium
Tumor Biology (2016)
-
BRCA1 mutations and luminal-basal transformation
Oncogene (2013)
-
Germline mutation of Brca1 alters the fate of mammary luminal cells and causes luminal-to-basal mammary tumor transformation
Oncogene (2013)
-
Breastfeeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers
Breast Cancer Research (2012)